Monday, March 12, 2012

Cellceutix Files Pre-IND Documentation to FDA for New Psoriasis Drug - MarketWatch (press release)

Cellceutix Files Pre-IND Documentation to FDA for New Psoriasis Drug MarketWatch (press release) Cellceutix has previously disclosed images of mice treated with Prurisol demonstrating its effectiveness As compared to methotrexate, type A standard care treatment for psoriasis today. More message on Prurisol can Be found at: ... and more » Link To Article

No comments:

Post a Comment